The United States Department of Health services has bought almost the entire next three month’s supply of breakthrough Coronavirus drug remdesivir for itself, leaving the rest of the world possibly without any supply for the next three months. Trump’s administration has bought the next 500,000 doses of the anti-viral drug, Remdesvir, from manufacturer Gilead, a figure that represents Gilead’s entire production for July, and 90% of …